Thrice daily consumption of a novel, premeal shot containing a low dose of whey protein increases time in euglycemia during 7 days of free-living in individuals with type 2 diabetes
Main Authors: | Mark Walker, Guy S Taylor, Kieran Smith, Emma J Stevenson, Daniel J West, Lise H Brunsgaard, Kelly A Bowden Davies |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-05-01
|
Series: | BMJ Open Diabetes Research & Care |
Online Access: | https://drc.bmj.com/content/10/3/e002820.full |
Similar Items
-
The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial
by: Kieran Smith, et al.
Published: (2021-06-01) -
The Clinical Application of Mealtime Whey Protein for the Treatment of Postprandial Hyperglycaemia for People With Type 2 Diabetes: A Long Whey to Go
by: Kieran Smith, et al.
Published: (2020-10-01) -
Comparison of Thrice-daily Novomix Insulin Versus Insulin Glargine Once-Daily Combined with Thrice-Daily Insulin Aspart on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
by: Seyyed Hossein Mirtorabi, et al.
Published: (2024-08-01) -
Gq signaling in α cells is critical for maintaining euglycemia
by: Liu Liu, et al.
Published: (2021-12-01) -
Twice Bitten, Thrice Shy
by: Stephanie Wiltshire, BMed, et al.
Published: (2021-03-01)